Eng

Patent Granted for Dymax's HLC™ Technology

PR Newswire (美通社)
更新於 7小時前 • 發布於 7小時前 • PR Newswire

Novel Adhesive Solution Offers Curing in Light and Darkness and Bonding to Various Substrates
Including Opaque Materials Impermeable to Light

SINGAPORE, Nov. 6, 2024 /PRNewswire/ -- Dymax, a leading manufacturer of rapid curing materials and equipment, has been granted a patent for its HLC™ (Hybrid Light-Curable) adhesive platform. The new technology combines the optimal qualities of anionic polymerization and free radical chemistries into one formulation.

Dymax HLC™ (Hybrid Light-Curable) Technology Provides Curing in Light and Darkness and Bonding of Opaque Substrates
廣告(請繼續閱讀本文)

Dymax HLC™ (Hybrid Light-Curable) Technology Provides Curing in Light and Darkness and Bonding of Opaque Substrates

The newly patented HLC technology aims to improve the curing performance of urethane (meth)acrylate compositions commonly used to formulate coatings, adhesives, sealants, and inks. Primary advantages of HLC™ include fast cure, low-to-no blooming after proper light cure, better aesthetics, humidity resistance, and more flexible joints than ordinary cyanoacrylates.

While standard light-curing materials cure effectively using UV/Visible light, they often struggle in areas where the light cannot reach, leaving behind uncured areas. These shadowed regions not only compromise the reliability of the final product but can also weaken adhesive bonds over time. HLC addresses the issue of incomplete curing in dark areas with rapid moisture/contact cure capability. Bonding to a broad range of substrates, including opaque and light-blocking materials, is also possible.

廣告(請繼續閱讀本文)

Due to the composition of their light-curing component, Dymax HLC adhesives form a cross-linked polymer framework, enabling the successful bonding of small gaps or larger joints. Light-curing also reduces the risk of "blooming," a common issue with cyanoacrylates, where a white residue forms at the edges of bond lines when they react with ambient humidity. Light-curing can significantly reduce the risk of blooming as the material cross-links before the monomer can volatilize.

Dymax HLC-M-1000, the first adhesive in the series, is engineered for medical applications and meets several biocompatibility standards. Its light-curing capabilities allow for rapid curing in seconds with low-intensity light, optimizing performance even at ~20 mW/cm². With an extremely low viscosity of 3 cP, the material is capable of wicking into extremely tight bond joints not typically accessible with other, higher-viscosity adhesives.

"HLC™ technology fills a gap that many manufacturers using light-curing technology face when bonding opaque substrates," said Dr. Ahmet Nebioglu, Dymax Sr. R&D Director, Global. "It balances the need for rapid cure in light or darkness while addressing the issues of blooming, low impact resistance, and limited long-term moisture exposure. This new technology is a major breakthrough for adhesion quality in the manufacturing process."

廣告(請繼續閱讀本文)

This advancement may provide greater product reliability for end users through improved curing, stronger bonds, and enhanced durability, contributing to the overall quality of finished components.

For technical inquiries about patented HLC technology, a team of Dymax application engineers and system integrators is available to develop customized dispensing solutions for users, assist with material handling challenges, and support customers throughout the manufacturing process.

About Dymax

Dymax develops innovative rapid and light-curable materials, dispense equipment, and UV/LED light-curing systems. The company's adhesives, coatings, and equipment are perfectly matched to work seamlessly with each other, providing design engineers with tools to dramatically improve manufacturing efficiencies. Major markets include aerospace and defense, medical device, and consumer and automotive electronics.

For additional information on Dymax, visit or call us at +65 6752 2887.

查看原始文章

更多 Eng 相關文章

China issues guidelines to promote development of ice, snow economy
XINHUA
ATRenew to Report Third Quarter 2024 Financial Results on November 20, 2024
PR Newswire (美通社)
U.S. Capitol Police arrests man carrying torch, flare gun on Election Day
XINHUA
Xi stresses high-quality development of social work
XINHUA
Xinhua Silk Road: Yangtze River culture and art season wraps up in C. China Hubei Yichang
PR Newswire (美通社)
Trump declares victory in election night speech addressing supporters
XINHUA
1st microsatellite developed by Chinese, Russian college students launched
XINHUA
GTI Initiates Global Recruitment for Intelligent RAN, Ubiquitous AI Project of 5G-A×AI Development Program
PR Newswire (美通社)
Xi urges Hubei to write its own chapter in Chinese modernization
XINHUA
Overwhelming majority of business entities in China from private sector
XINHUA
Letter from Lhasa: Xizang revisited -- A fresh narrative
XINHUA
Xinhua News | China-Laos Railway sees passengers up 44 pct in 10 months
XINHUA
HTX Ventures: Fueling Exchanges' Transformation into Hubs for DeFi-related Services through Education and Diversification, Empowering investors to Manage Risks and Liquidity in a Volatile Market
PR Newswire (美通社)
Thailand announces 2025 as the "Amazing Thailand Grand Tourism and Sports Year"
PR Newswire (美通社)
ASH 2024 | Results From Three Clinical Studies of Ascentage Pharma's Bcl-2 Inhibitor Lisaftoclax Selected for Presentations, Including an Oral Report
PR Newswire (美通社)
Beijing beefs up protection of ancient tree clusters along Central Axis
XINHUA
ASH 2024 | Studies of Olverembatinib Selected for Presentations, Including an Oral Report, for the Seventh Consecutive Year
PR Newswire (美通社)
Green innovations at Canton Fair showcase China's industrial vitality
XINHUA
2024 EdTech Awards Recognize HiTeach as One of the Best in Teaching Software
PR Newswire (美通社)
Media project Trump to have won at least 270 electoral college votes
XINHUA
New Zealand steps up participation, highlights confidence in CIIE
XINHUA
Record Breaking Participation at Largest Taiwan Creative Content Festival Yet Drives Investment Potential
PR Newswire (美通社)
Straits Financial Services Pte Ltd Successfully Participated First Trades of CME Group's Spodumene Futures
PR Newswire (美通社)
On the sidelines of Singapore Fintech Festival 2024
PR Newswire (美通社)
Update: Xi stresses high-quality development of social work
XINHUA
CNOOC Limited Brings On-stream Long Lake NW Project in Canada
PR Newswire (美通社)
China-aided airport to enhance connectivity, spur economic growth in Pakistan's Gwadar
XINHUA
China's top political advisor meets speaker of Hungarian National Assembly
XINHUA
Mastercard goes OTP-free in APAC for faster, safer online transactions
PR Newswire (美通社)
(CIIE) Vlog | Newcomers at CIIE: How does it feel to board a future "air taxi"?
XINHUA
Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
PR Newswire (美通社)
Chunghwa Telecom Reports Un-Audited Consolidated Operating Results for the Third Quarter of 2024
PR Newswire (美通社)
Xinhua News | Xi urges accelerating rural revitalization
XINHUA
Tourism, culture help cement China-Tanzania ties: officials
XINHUA
The 136th Canton Fair Advances High-Quality Development of International Trade with Overseas Buyers Attendance Hitting Record Numbers
PR Newswire (美通社)
First steel-truss beam hoisted on Huajiang Grand Canyon Bridge
XINHUA
ATFX Wins Two Awards at the 2024 International Investor Awards
PR Newswire (美通社)
Hanmi Unveils Novel Obesity Drug 'HM17321' : A Game-Changer in Overcoming GLP-1-Associated Muscle Loss
PR Newswire (美通社)
Zambian firm seeks to explore Chinese market at CIIE
XINHUA